These candidates, which are generally increased in COVID-19 patients [47,48], might indicate a risk for CAPA, given the fact that IL-8 and caspase-3 levels increase in hematological patients after Aspergillus infection (Figure 5). Here, CASP3 is linked to episodic ataxia type 2.